Austrian Biotech Database

Biotechgate

Biotechgate Global Database › Global Trial › Global Log-in ›

Database Life Science Map Statistics News & Events About us

News in the Life Sciences Industry
Results 1 - 20 out of 101 displayed.
1 2 3 4 5 6 »

Novo Nordisk A/S – Share repurchase programme

Read more ››

By: GlobenewsWire - 14 Feb 2020

Trading in Novo Nordisk shares by board members, executives and associated persons on 11 February 2020

Read more ››

By: GlobenewsWire - 14 Feb 2020

Trading in Novo Nordisk shares by board members, executives and associated persons on 7 February 2020

Read more ››

By: GlobenewsWire - 11 Feb 2020

Trading in Novo Nordisk shares by board members, executives and associated persons on 5 - 8 February 2020

Read more ››

By: GlobenewsWire - 10 Feb 2020

Sanofi: Disclosure of trading in own shares

Read more ››

By: GlobenewsWire - 10 Feb 2020

Sanofi delivers strong 2019 business EPS growth of 6.8% at CER

Read more ››

By: GlobenewsWire - 06 Feb 2020

Sanofi : Sanofi brain-penetrant BTK inhibitor meets primary endpoint of Phase 2 trial in relapsing multiple sclerosis

Read more ››

By: GlobenewsWire - 06 Feb 2020

Novo Nordisk's operating profit increased by 11% in Danish kroner and by 6% at constant exchange rates (CER) in 2019

Read more ››

By: GlobenewsWire - 05 Feb 2020

Novo Nordisk A/S – Share repurchase programme

Read more ››

By: GlobenewsWire - 04 Feb 2020

Valneva Announces New $85 Million Financing Arrangement with Leading US Healthcare Funds Deerfield and OrbiMed

Read more ››

By: GlobenewsWire - 03 Feb 2020

Sanofi: Disclosure of trading in own shares

Read more ››

By: GlobenewsWire - 03 Feb 2020

Rybelsus® (oral semaglutide) recommended for approval for the treatment of adults with type 2 diabetes by the European regulatory authorities

Read more ››

By: GlobenewsWire - 31 Jan 2020

Sanofi : Positive topline results demonstrated by olipudase alfa, first and only investigational therapy in late-stage development for acid sphingomyelinase deficiency

Read more ››

By: GlobenewsWire - 30 Jan 2020

Sanofi : FDA accepts for priority review Dupixent® (dupilumab) for children aged 6 to 11 years with moderate-to-severe atopic dermatitis

Read more ››

By: GlobenewsWire - 28 Jan 2020

Novo Nordisk A/S – Share repurchase programme

Read more ››

By: GlobenewsWire - 27 Jan 2020

Sanofi: Disclosure of trading in own shares

Read more ››

By: GlobenewsWire - 27 Jan 2020

Sanofi : Sanofi Completes Acquisition of Synthorx, Inc.

Read more ››

By: GlobenewsWire - 23 Jan 2020

Novo Nordisk A/S – Share repurchase programme

Read more ››

By: GlobenewsWire - 20 Jan 2020

Sanofi: Disclosure of trading in own shares

Read more ››

By: GlobenewsWire - 20 Jan 2020

Sanofi : Hart-Scott-Rodino waiting period expires for Sanofi’s acquisition of Synthorx

Read more ››

By: GlobenewsWire - 20 Jan 2020

Looking for companies outside of Austria?

Browse our global Life Sciences lead sourcing platform Biotechgate for company information, product pipelines, licensing opportunities, management details and much more.

Partners

Upcoming Life Sciences Events

February 2020
- Zurich: European HealthTech CEO Forum
- Zurich: 13th Annual European Life Sciences CEO Forum
- Lisbon: Liquid Biopsy 2020

Add an Event »

Latest company news

Novo Nordisk A/S – Share repurchase programme
14 Feb 2020 (GlobenewsWire)

Trading in Novo Nordisk shares by board members, executives and associated persons on 11 February 2020
14 Feb 2020 (GlobenewsWire)

Trading in Novo Nordisk shares by board members, executives and associated persons on 7 February 2020
11 Feb 2020 (GlobenewsWire)

Biotechgate database

About Biotechgate
The Austrian Biotech Database is a product of Venture Valuation and part of the global Life Sciences lead generation and intelligence platform Biotechgate. Our mission is to provide up-to-date company and business information of the Biotech, Pharma and Medtech sectors to professionals everywhere, in order to support them in identifying the most appropriate business partners, customers and suppliers.

Visit our global portal: www.biotechgate.com